Details

Annex 13 to the Good manufacturing practices guide for drugs used in clinical trials (GUI-0036): Overview - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 11, 2026 · edition #6
Timestamp: 2026-04-11T15:05:18.927Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-13-guide-drugs-clinical-trials-0036.html
Replay URL: https://replay.healtharchive.ca/job-6/20260411150518/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-13-guide-drugs-clinical-trials-0036.html#ha_snapshot=371674
ID: 371674
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots